Casi Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary

CASI Pharmaceuticals

13/05/2021 18:20

* CASI Pharmaceuticals Inc  CASI.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 6 cents per share.
* Revenue rose 68.4% to $5.74 million from a year ago;  analysts
expected $5.05 million. 
* The mean earnings estimate of analysts had risen by
about 14.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* CASI Pharmaceuticals Inc shares had fallen by 39.6% this
quarter and lost 50.8% so far this year.
* The company reported a quarterly loss of $13.88 million.
* Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $3.80 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 05:20 p.m. GMT.
​All figures in US dollars